Detalles de la búsqueda
1.
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study.
BMC Cancer
; 19(1): 896, 2019 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500587
2.
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017.
BJU Int
; 124(3): 373-382, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077523
3.
Health-related quality of life and psychological distress among cancer survivors in a middle-income country.
Psychooncology
; 27(9): 2172-2179, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29856903
4.
Real-world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed-dose combination to prevent chemotherapy-induced nausea and vomiting among Malaysian patients receiving moderately or highly emetogenic chemotherapy.
Asia Pac J Clin Oncol
; 18(4): 419-427, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811924
5.
Retrospective Analysis of Cancer Care Performance and Survival Outcome for Nasopharyngeal Carcinoma at a leading Cancer Treatment Centre in Malaysia 2008-2012.
Asian Pac J Cancer Prev
; 20(6): 1701-1708, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31244290
6.
Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action.
J Oncol Pract
; 15(6): e537-e546, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31112479
7.
Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study.
Oncol Lett
; 11(4): 2757-2762, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27073548
8.
Breast Cancer Survival at a Leading Cancer Centre in Malaysia.
Asian Pac J Cancer Prev
; 16(18): 8513-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26745110
Resultados
1 -
8
de 8
1
Próxima >
>>